Expression and characterization of VPAC2 in CHO cells.
- Author:
Rong-Jie YU
1
;
Yuan GAO
;
Yun DAI
;
Ngai-lik TAM
;
Zhi-Hong ZENG
;
Tian-Hong ZHOU
;
An HONG
Author Information
1. Bio-engineering Institute of Jinan University, Guangzhou 510632, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Binding, Competitive;
CHO Cells;
Cell Membrane;
drug effects;
metabolism;
Cricetinae;
Cricetulus;
Cyclic AMP;
metabolism;
Gene Expression;
Genetic Vectors;
genetics;
Iodine Radioisotopes;
chemistry;
Pituitary Adenylate Cyclase-Activating Polypeptide;
chemistry;
metabolism;
pharmacology;
Receptors, Vasoactive Intestinal Peptide, Type II;
agonists;
antagonists & inhibitors;
genetics;
metabolism;
Reverse Transcriptase Polymerase Chain Reaction;
Transfection
- From:
Chinese Journal of Biotechnology
2006;22(6):996-1001
- CountryChina
- Language:Chinese
-
Abstract:
VPAC2 is a co-receptor of pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) and mediates multiple bio-functions. In order to construct the CHO line expressing VPAC2 stably, pcDNA-VPAC2 was used to transfect CHO cells. The positive clones were selected by G418 and the clone VPAC2-CHO with high sensitivity to PACAP38 was picked out by its ability to promoting the concentration of cAMP. RT-PCR, Western blot and Immunofluorescenece assay were used to identify the express of VPACS. Binding competition with VPAC2 agonist and the bioactivity of mediating the ligand to promote the concentration of cAMP showed that VPAC2 was expressed effectively in VPAC2-CHO. The results of Scatchard analysis revealed that VAPC2-CHO expressed a receptor density of (1.1 +/- 0.2) pmol/mg protein, respectively, with Kd values of (0.55 +/- 0.10) nmol/L for PACAP38 used as a tracer. The construction of CHO cells expressing VPAC2 specially and functionally lays a foundation not only for the further research on the characters and functions of VPAC2 but also for the screening and characterization of novel agonists of antagonists for VPAC2.
